Видео с ютуба Biogen Update

Biogen CEO Chris Viehbacher on 2026 drug pipeline outlook, rare disease strategy

Препарат для лечения болезни Альцгеймера от Eisai и Biogen получил одобрение FDA

Biogen’s new Alzheimer’s treatment: What to know

What’s The Controversy Behind Biogen’s Alzheimer’s Drug?

FDA approves Biogen Alzheimer's treatment

Генеральный директор Biogen об одобрении FDA препарата от болезни Альцгеймера

From RTP to the World: How Biogen Is Transforming Health and Community

Breakingviews TV: Biogen’s drug

Biogen to seek FDA approval for Alzheimer's drug Aducanumab

Cramer: Biogen's Alzheimer's treatment would be 'the biggest drug ever'

Study finds Biogen conference likely led to 20,000 COVID-19 cases

FDA approves Biogen's Alzheimer's drug

FDA's historic approval of Biogen's Alzheimer's drug

Biogen validates anti-tau approach at AAIC, psychedelics full speed ahead, ATTR-CM shakeup

News Update: Biogen Idec Inc. CEO & COO to Retire, Company Announces Changes in Management (BIIB)

Biogen Alzheimer's drug closer to approval

FDA recommends Biogen's Alzheimer's drug for approval

FDA approves Alzheimer's drug from Cambridge-based Biogen